Global Biologic Therapeutic Drug Market Size, Status and Forecast 2024-2034
Global Biologic Therapeutic Drug Scope and Market Size
Biologic Therapeutic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Segment by Application
Clinical Medicine
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aurobindo Pharma Ltd.
Concord Biotech
GlaxoSmithKline Plc.
H. Lundbeck A/S
Novartis Global
Retractable Technologies, Inc.
Smith Medical
AstraZeneca
Pfizer Inc.
Merck and Co. Inc.

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Proteins
1.2.4 Vaccines
1.3 Market by Application
1.3.1 Global Biologic Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Medicine
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biologic Therapeutic Drug Market Perspective (2016-2027)
2.2 Biologic Therapeutic Drug Growth Trends by Regions
2.2.1 Biologic Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biologic Therapeutic Drug Historic Market Share by Regions (2016-2021)
2.2.3 Biologic Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
2.3 Biologic Therapeutic Drug Industry Dynamic
2.3.1 Biologic Therapeutic Drug Market Trends
2.3.2 Biologic Therapeutic Drug Market Drivers
2.3.3 Biologic Therapeutic Drug Market Challenges
2.3.4 Biologic Therapeutic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Therapeutic Drug Players by Revenue
3.1.1 Global Top Biologic Therapeutic Drug Players by Revenue (2016-2021)
3.1.2 Global Biologic Therapeutic Drug Revenue Market Share by Players (2016-2021)
3.2 Global Biologic Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biologic Therapeutic Drug Revenue
3.4 Global Biologic Therapeutic Drug Market Concentration Ratio
3.4.1 Global Biologic Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Therapeutic Drug Revenue in 2020
3.5 Biologic Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Biologic Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Biologic Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Therapeutic Drug Breakdown Data by Type
4.1 Global Biologic Therapeutic Drug Historic Market Size by Type (2016-2021)
4.2 Global Biologic Therapeutic Drug Forecasted Market Size by Type (2022-2027)
5 Biologic Therapeutic Drug Breakdown Data by Application
5.1 Global Biologic Therapeutic Drug Historic Market Size by Application (2016-2021)
5.2 Global Biologic Therapeutic Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biologic Therapeutic Drug Market Size (2016-2027)
6.2 North America Biologic Therapeutic Drug Market Size by Type
6.2.1 North America Biologic Therapeutic Drug Market Size by Type (2016-2021)
6.2.2 North America Biologic Therapeutic Drug Market Size by Type (2022-2027)
6.2.3 North America Biologic Therapeutic Drug Market Size by Type (2016-2027)
6.3 North America Biologic Therapeutic Drug Market Size by Application
6.3.1 North America Biologic Therapeutic Drug Market Size by Application (2016-2021)
6.3.2 North America Biologic Therapeutic Drug Market Size by Application (2022-2027)
6.3.3 North America Biologic Therapeutic Drug Market Size by Application (2016-2027)
6.4 North America Biologic Therapeutic Drug Market Size by Country
6.4.1 North America Biologic Therapeutic Drug Market Size by Country (2016-2021)
6.4.2 North America Biologic Therapeutic Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biologic Therapeutic Drug Market Size (2016-2027)
7.2 Europe Biologic Therapeutic Drug Market Size by Type
7.2.1 Europe Biologic Therapeutic Drug Market Size by Type (2016-2021)
7.2.2 Europe Biologic Therapeutic Drug Market Size by Type (2022-2027)
7.2.3 Europe Biologic Therapeutic Drug Market Size by Type (2016-2027)
7.3 Europe Biologic Therapeutic Drug Market Size by Application
7.3.1 Europe Biologic Therapeutic Drug Market Size by Application (2016-2021)
7.3.2 Europe Biologic Therapeutic Drug Market Size by Application (2022-2027)
7.3.3 Europe Biologic Therapeutic Drug Market Size by Application (2016-2027)
7.4 Europe Biologic Therapeutic Drug Market Size by Country
7.4.1 Europe Biologic Therapeutic Drug Market Size by Country (2016-2021)
7.4.2 Europe Biologic Therapeutic Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biologic Therapeutic Drug Market Size (2016-2027)
8.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Type
8.2.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Application
8.3.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Biologic Therapeutic Drug Market Size by Region
8.4.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biologic Therapeutic Drug Market Size (2016-2027)
9.2 Latin America Biologic Therapeutic Drug Market Size by Type
9.2.1 Latin America Biologic Therapeutic Drug Market Size by Type (2016-2021)
9.2.2 Latin America Biologic Therapeutic Drug Market Size by Type (2022-2027)
9.2.3 Latin America Biologic Therapeutic Drug Market Size by Type (2016-2027)
9.3 Latin America Biologic Therapeutic Drug Market Size by Application
9.3.1 Latin America Biologic Therapeutic Drug Market Size by Application (2016-2021)
9.3.2 Latin America Biologic Therapeutic Drug Market Size by Application (2022-2027)
9.3.3 Latin America Biologic Therapeutic Drug Market Size by Application (2016-2027)
9.4 Latin America Biologic Therapeutic Drug Market Size by Country
9.4.1 Latin America Biologic Therapeutic Drug Market Size by Country (2016-2021)
9.4.2 Latin America Biologic Therapeutic Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Therapeutic Drug Market Size (2016-2027)
10.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type
10.2.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application
10.3.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Biologic Therapeutic Drug Market Size by Country
10.4.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aurobindo Pharma Ltd.
11.1.1 Aurobindo Pharma Ltd. Company Details
11.1.2 Aurobindo Pharma Ltd. Business Overview
11.1.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Introduction
11.1.4 Aurobindo Pharma Ltd. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.1.5 Aurobindo Pharma Ltd. Recent Development
11.2 Concord Biotech
11.2.1 Concord Biotech Company Details
11.2.2 Concord Biotech Business Overview
11.2.3 Concord Biotech Biologic Therapeutic Drug Introduction
11.2.4 Concord Biotech Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.2.5 Concord Biotech Recent Development
11.3 GlaxoSmithKline Plc.
11.3.1 GlaxoSmithKline Plc. Company Details
11.3.2 GlaxoSmithKline Plc. Business Overview
11.3.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Introduction
11.3.4 GlaxoSmithKline Plc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.3.5 GlaxoSmithKline Plc. Recent Development
11.4 H. Lundbeck A/S
11.4.1 H. Lundbeck A/S Company Details
11.4.2 H. Lundbeck A/S Business Overview
11.4.3 H. Lundbeck A/S Biologic Therapeutic Drug Introduction
11.4.4 H. Lundbeck A/S Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.4.5 H. Lundbeck A/S Recent Development
11.5 Novartis Global
11.5.1 Novartis Global Company Details
11.5.2 Novartis Global Business Overview
11.5.3 Novartis Global Biologic Therapeutic Drug Introduction
11.5.4 Novartis Global Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.5.5 Novartis Global Recent Development
11.6 Retractable Technologies, Inc.
11.6.1 Retractable Technologies, Inc. Company Details
11.6.2 Retractable Technologies, Inc. Business Overview
11.6.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Introduction
11.6.4 Retractable Technologies, Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.6.5 Retractable Technologies, Inc. Recent Development
11.7 Smith Medical
11.7.1 Smith Medical Company Details
11.7.2 Smith Medical Business Overview
11.7.3 Smith Medical Biologic Therapeutic Drug Introduction
11.7.4 Smith Medical Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.7.5 Smith Medical Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Biologic Therapeutic Drug Introduction
11.8.4 AstraZeneca Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Biologic Therapeutic Drug Introduction
11.9.4 Pfizer Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.9.5 Pfizer Inc. Recent Development
11.10 Merck and Co. Inc.
11.10.1 Merck and Co. Inc. Company Details
11.10.2 Merck and Co. Inc. Business Overview
11.10.3 Merck and Co. Inc. Biologic Therapeutic Drug Introduction
11.10.4 Merck and Co. Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.10.5 Merck and Co. Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details